Cumulative Covid vaccine doses administered in India cross 55 crore: Govt

The cumulative COVID-19 vaccine doses administered in the country surpassed the 55 crore-mark on Monday, he Union health ministry said.

Topics
Coronavirus Vaccine | Vaccination | Health Ministry

Press Trust of India  |  New Delhi 

Visitors wait to get their dose of Covid-19 vaccine at an inoculation centre in Bikaner, Sunday, Aug. 8, 2021. (PTI Photo)
Visitors wait to get their dose of Covid-19 vaccine at an inoculation centre in Bikaner. (PTI Photo)

The cumulative COVID-19 vaccine doses administered in the country surpassed the 55 crore-mark on Monday, he Union said.

"In record-breaking progress, India administers 55 crore #COVID19 vaccines. Let's strengthen India's fight against Let's get vaccinated!" Union Health Minister Mansukh Mandaviya said in a tweet on Monday afternoon.

India took 85 days to touch the figure of 10 crores. It then took 45 days to cross the 20 crore-mark, 29 days more to reach 30 crores. India took 24 days to reach 40 crore from 30 crore and then 20 more days to cross 50 crore vaccinations on August 6. It surpassed the 54 crore-mark on August 14.

The countrywide drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated and of frontline workers (FLWs) starting from February 2.

The next phase of COVID-19 commenced from March 1 for those over 60 years of age and for people aged 45 and above with specified co-morbid conditions.

India launched the vaccination drive for all people aged more than 45 from April 1.

The government then decided to expand its vaccination drive by allowing everyone above 18 eligible to be vaccinated from May 1.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Mon, August 16 2021. 16:04 IST
RECOMMENDED FOR YOU